MS Morgan Stanley
Wealth mix lifts the ROE floor, but 2.9x book still capitalizes peak capital-markets returns.
The story
Morgan Stanley is now a wealth-and-asset-management franchise wrapped around a top-tier institutional securities business. Fee-based wealth assets supply stable, capital-light earnings, and that mix has pushed through-cycle returns structurally higher. The current ~20% ROE, however, rests on peak conditions: record trading, a strong M&A/ECM rebound, and elevated asset levels. Capital is strong (CET1 well above requirements), but the institutional half stays cyclical and market-sensitive, and the stock at ~2.9x book prices peak returns as permanent.
I raised normalized ROE only modestly, from 16% to 16.5%. ROE has now held near 20% for several more quarters, and wealth-management mix keeps growing, which supports a higher through-cycle floor. I still cap it well below trailing because about 40% of earnings are cyclical trading and banking, and reported book includes preferred equity. Book growth, beta, and failure risk are unchanged, because buybacks and dividends take most of the retained earnings and leverage plus market exposure justify an above-anchor beta.
Value drivers
| Return on equity (normalized) | 16.5% |
| Book-value growth (Y1) | 6.0% |
| Terminal book growth | 4.0% |
| Beta | 1.20 |
| Failure probability | 1.0% |
| Cost of equity | 10.6% |
Valuation bridge
| PV of excess returns | 31.21B |
| PV of terminal excess | 18.56B |
| Equity value | 150.14B |
| ÷ shares → per share | $96.06 |
Projected excess returns on equity
| Yr | Book equity | ROE | Excess return | PV |
|---|---|---|---|---|
| 1 | 101.88B | 16.5% | 6.06B | 5.48B |
| 2 | 107.99B | 16.1% | 5.95B | 4.87B |
| 3 | 114.23B | 15.6% | 5.79B | 4.29B |
| 4 | 120.58B | 15.2% | 5.58B | 3.74B |
| 5 | 127.01B | 14.7% | 5.32B | 3.22B |
| 6 | 133.50B | 14.3% | 5.01B | 2.74B |
| 7 | 140.03B | 13.9% | 4.64B | 2.30B |
| 8 | 146.57B | 13.4% | 4.22B | 1.89B |
| 9 | 153.08B | 13.0% | 3.73B | 1.51B |
| 10 | 159.54B | 12.6% | 3.19B | 1.17B |
Key risks
- Capital-markets downturn compresses trading and investment-banking revenue and drags ROE back toward 10-13%
- Equity bear market cuts fee-based wealth revenue linked to client assets and slows net new asset flows
- Regulatory capital changes (Basel endgame, SCB, G-SIB surcharge) restrict buybacks or raise required equity
Catalysts
- Delivering 20%+ ROTCE through a softer market quarter would validate a higher normalized ROE
- Final Basel III endgame relief releasing excess capital for larger buybacks